Decker Wealth Management LLC’s Pfizer PFE Stock Holding History

Decker Wealth Management LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,566	Closed	-$212K	–	110
2026 Q1	$212K	Buy	+7,566	New	+$201K	0.05%	103

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Decker Wealth Management LLC's PFE Position: Q2 2026 in Review

Decker Wealth Management LLC sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,566 shares — an estimated $212K sold.

Decker Wealth Management LLC first reported a position in PFE in Q1 2026 and held it in 1 quarter. The position peaked at $212K in Q1 2026. 2,815 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Decker Wealth Management LLC reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Decker Wealth Management LLC sold 7,566 Pfizer shares in Q2 2026, an estimated $212K.
Decker Wealth Management LLC first reported a position in Pfizer in Q1 2026 and held it in 1 quarter.
Decker Wealth Management LLC's Pfizer position peaked at $212K in Q1 2026.
2,815 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Decker Wealth Management LLC's 13F filing for Q2 2026, filed 30 Jul 2026.